The launch of a 750mcg PTH injection in Australia has been somewhat restricted , with availability primarily via specialist physicians and designated hospitals . Initial distribution numbers for this increased strength remain confidential from the manufacturer , although reports suggest gradual adoption rates . Patient access is governed by the sch